SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 1, 1998 ------------ NEOTHERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 0-28782 93-0979187 - -------------------------------------------------------------------------------- (State or other jurisdiction (Commission (IRS Employer (of incorporation) File Number) Identification No.) 157 Technology Drive, Irvine, California 92618 ------------------------------------------------------------------ (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (949) 788-6700 Not Applicable --------------------------------------- (Former name or former address, if changed since last report) (Telephone area code changed from (714) to (949) Page 1 of 5 Exhibit Index on Page 3 ITEM 5. OTHER EVENTS Reference is made to Exhibit 99.1 filed with this Report, which is a transcript of a "Message from the President" dated June 1, 1998, that will be included on the Registrant's world wide web site at www.neotherapeutics.com. ITEM 7. EXHIBITS EXHIBIT: 99.1 TRANSCRIPT OF REGISTRANT'S WEB SITE PAGE DATED JUNE 1, 1998. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. NEOTHERAPEUTICS, INC. Date: June 1, 1998 By: /s/Samuel Gulko --------------------------------- Samuel Gulko Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description ----------- ----------- 99.1 Transcript of Registrant's web site page dated June 1, 1998. 3